NextDC 1H25 underlying EBITDA up 3% to $105.4m, contracted utilisation up 18% to $176MW, net loss of $42.7m reflecting ...

A weekly summary of on-market ASX 200 director transactions valued at more than $10,000. The trades have all taken place ...

A recap of the most heavily shorted stocks on the ASX and those experiencing significant changes to short interest over the ...

A recap of S&P/ASX 200 stocks that have tagged a fresh yearly highs and lows in the past week. By tracking these 52-week ...

Data supplied by Morningstar and accurate on Aug 19, 2024. It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of ...

Yancoal reported a $1.2 billion net profit for 2024 and declared a $687 million final dividend or 52 cents per share.

Telix Pharmaceuticals 1H25 NPAT up 860% to $49.9m, FY25 revenue guidance of $1.18-1.23bn vs. $1.02bn consensus, R&D ...

124 Years of the Australian Stock Market A breakdown of the Australian stock market’s historical returns since 1900. Presented in an easy-to-digest visual layout. Updated October 2024.

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits) ...

Data supplied by Morningstar and accurate on Jun 30, 2024. It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of ...

Data supplied by Morningstar and accurate on Aug 15, 2024. It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of ...

CSL and Cochlear are two of Australia’s blue-chip healthcare stocks, stalwarts of many investors portfolios, whereas Pro ...